No Data
No Data
ARS Pharmaceuticals Announces Conference Call and Webcast for Its Fourth Quarter and Full Year 2024 Financial Results and Participation at Upcoming Conferences
William Blair Maintains ARS Pharmaceuticals(SPRY.US) With Buy Rating
ARS Pharmaceuticals Secures Major Formulary Wins, Strengthens Market Position for Neffy
William Blair Initiates ARS Pharmaceuticals(SPRY.US) With Buy Rating
Express News | ARS Pharmaceuticals Announces Optumrx, Cigna Healthcare and Navitus Health Systems Add Neffy® (Epinephrine Nasal Spray) to National Formularies, Further Expanding Coverage for Patients
ARS Pharmaceuticals Announces OptumRx, Cigna Healthcare and Navitus Health Systems Add Neffy (Epinephrine Nasal Spray) to National Formularies, Further Expanding Coverage for Patients